Camille L Swartz

Camille L Swartz,

Clinical Research Coordinator III

Department: MD-NEUROLOGY-MOVEMENT DISORDER
Business Phone: (352) 733-2429

Publications

2014
A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit.
JAMA neurology. 71(5):543-52 [DOI] 10.1001/jamaneurol.2014.131. [PMID] 24664227.
2012
Selection of deep brain stimulation candidates in private neurology practices: referral may be simpler than a computerized triage system.
Neuromodulation : journal of the International Neuromodulation Society. 15(3):246-50; discussion 250 [DOI] 10.1111/j.1525-1403.2012.00437.x. [PMID] 22376158.
2010
Prevalence and characteristics of punding and repetitive behaviors among Parkinson patients in North-Central Florida.
International journal of geriatric psychiatry. 25(5):540-1 [DOI] 10.1002/gps.2324. [PMID] 20391589.
2003
Respiratory response to activation or disinhibition of the dorsal periaqueductal gray in rats.
Journal of applied physiology (Bethesda, Md. : 1985). 94(3):913-22 [PMID] 12571126.

Grants

Nov 2021 – Jun 2023
A PHASE IIB, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF INTRAVENOUS PRASINEZUMAB IN PARTICIPANTS WITH EARLY PARKINSON'S DISEASE
Role: Other
Funding: GENENTECH INC
Oct 2020 – Oct 2025
A Phase 3, 4-week, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of TD-9855 in Treating Symptomatic Neurogenic Orthostatic Hypotension in Subjects With Primary Autonomic Failure
Role: Other
Funding: IQVIA Holdings via DRUGDEV INC
May 2020 ACTIVE
Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of 36 Weeks of Treatment with NLY01 in Early-stage Parkinsons Disease
Role: Other
Funding: RHO INC via NEURALY
Jan 2020 – Jan 2025
Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients with ALS: Open-Label Extension for Patients Completing Study 3119002
Role: Other
Funding: PHARMACEUTICAL RES ASSO via ORION CORP
Aug 2018 – Aug 2023
Local Field Potential Beta Adaptive Deep Brain Stimulation Feasibility Study (LFP Beta aDBS Feasibility Study)
Role: Other
Funding: MEDTRONIC INC

Contact Details

Phones:
Business:
(352) 733-2429
Emails:
Addresses:
Business Mailing:
PO Box 112742
GAINESVILLE FL 32611
Business Street:
3009 SW WILLISTON RD
GAINESVILLE FL 32608